High Net Worth Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
High Net Worth Advisory Group's NVS Position: Q3 2026 in Review
High Net Worth Advisory Group held its Novartis (NVS) position steady in Q3 2026 at 2,779 shares worth $396K. The position accounts for 0.08% of the portfolio, ranked #181.
High Net Worth Advisory Group first reported a position in NVS in Q4 2021 and has held it in 20 quarters since. The position peaked at $436K in Q2 2026. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- High Net Worth Advisory Group held 2,779 shares of Novartis worth $396K as of Q3 2026.
- High Net Worth Advisory Group left its Novartis share count unchanged in Q3 2026.
- Novartis made up 0.08% of High Net Worth Advisory Group's portfolio in Q3 2026, its #181 holding.
- High Net Worth Advisory Group first reported a position in Novartis in Q4 2021 and has held it in 20 quarters since.
- High Net Worth Advisory Group's Novartis position peaked at $436K in Q2 2026.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on High Net Worth Advisory Group's 13F filing for Q3 2026, filed 26 Oct 2026.